Pazopanib in the management of advanced soft tissue sarcomas
Lee D Cranmer,1 Elizabeth T Loggers,2 Seth M Pollack2 1Division of Medical Oncology, University of Washington, Seattle, WA, USA; 2Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Abstract: Therapy of soft tissue sarcomas represents an area of significant unmet nee...
Saved in:
Main Authors: | Cranmer LD (Author), Loggers ET (Author), Pollack SM (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Propranolol for the treatment of vascular sarcomas
by: Wagner MJ, et al.
Published: (2018) -
Pazopanib for the treatment of soft-tissue sarcoma
by: Heudel P, et al.
Published: (2012) -
Effect of Acid‐Suppressive Strategies on Pazopanib Efficacy in Patients With Soft‐Tissue Sarcoma
by: Sorana G. Pisano, et al.
Published: (2019) -
Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients
by: Marie-Sophie, et al.
Published: (2022) -
Trabectedin for advanced soft tissue sarcomas: optimizing use
by: Reid A, et al.
Published: (2014)